Progress in Clinical Trials of Chemical Modified New Drugs in China

Yang Lixiang, Lin Lin, Tian Lijuan

Chinese Pharmaceutical Affairs ›› 2024, Vol. 38 ›› Issue (8) : 860-868.

PDF(1034 KB)
PDF(1034 KB)
Chinese Pharmaceutical Affairs ›› 2024, Vol. 38 ›› Issue (8) : 860-868. DOI: 10.16153/j.1002-7777.20240383
Supervision & Administration

Progress in Clinical Trials of Chemical Modified New Drugs in China

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 38(8): 860-868 https://doi.org/10.16153/j.1002-7777.20240383

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1034 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉